Larry Robbins's BIIB Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 290,605 shares of Biogen Inc. (BIIB) worth $51.14 M, representing 1.04% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Larry Robbins has initiated a new position in BIIB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Biogen (BIIB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Biogen (BIIB) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +290,605 | New Buy | 290,605 | $175.99 |
Larry Robbins's Biogen Investment FAQs
Larry Robbins first purchased Biogen Inc. (BIIB) in Q4 2025, acquiring 290,605 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Biogen Inc. (BIIB) for 1 quarters since Q4 2025.
Larry Robbins's largest addition to Biogen Inc. (BIIB) was in Q4 2025, adding 290,605 shares worth $51.14 M.
According to the latest 13F filing for Q4 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 290,605 shares of Biogen Inc. (BIIB), valued at approximately $51.14 M.
As of the Q4 2025 filing, Biogen Inc. (BIIB) represents approximately 1.04% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Biogen Inc. (BIIB) was 290,605 shares, as reported at the end of Q4 2025.